Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clearbridge HealthSGX:1H3 Net Margin % is -37.12% as of Jun. 2026. The stock has 4 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, Clearbridge Health ranks worse than 83.74% on this metric.
The historical rank and industry rank for Clearbridge Health's Net Margin % or its related term are showing as below:
SGX:1H3'
s Net Margin % Range Over the Past 10 Years
Min: -2593.75 Med: -152.27 Max: 1.7
Current: -175.06
SGX:1H3's Net Margin % is ranked worse than 83.74% of 203
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.74
vs SGX:1H3: -175.06
Clearbridge Health (SGX:1H3) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Clearbridge Health Net Margin % Related Terms
Clearbridge Health Net Margin % Historical Data
* Premium members only.
The historical data trend for Clearbridge Health's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:1H3 vs TMO, DHR, IDXX: Net Margin % Comparison
For the Diagnostics & Research subindustry, Clearbridge Health's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clearbridge Health Net Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Clearbridge Health's Net Margin % distribution charts can be found below:
* The bar in red indicates where Clearbridge Health's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clearbridge Health (SGX:1H3) has a Net Margin % of -37.12% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Clearbridge Health and its competitors. According to the industry distribution chart, Clearbridge Health ranks #170 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 83.7%.
Is Clearbridge Health's Net Margin % too high?
Clearbridge Health's current Net Margin % is -37.12%. Based on the distribution chart, Clearbridge Health ranks #170 out of 203 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Clearbridge Health's Net Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Clearbridge Health ranks #170 out of 203 companies for Net Margin %. This places Clearbridge Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Clearbridge Health and its competitors. Clearbridge Health's current Net Margin % is -37.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clearbridge Health stock overvalued right now?
Clearbridge Health (SGX:1H3) has a current Net Margin % of -37.12%. The current Net Margin % is -37.12%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Clearbridge Health (SGX:1H3), the current Net Margin % is -37.12% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments are Strategic investments; Others ; Medical clinics; Corporate segment and Investment. It derives key revenue from the Medical clinics segment. The medical clinics/centres segment involves the provision of general medical, dental and clinical services and distribution of the medical and pharmaceutical products. The group has a business presence in Singapore, Philippines, Hong Kong, Malaysia and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:1H3 has been successfully added to your 
